Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis' Alcon unit recalls eye drop vials over questionable sterility
Fierce Pharma Manufacturing
Tue, 03/1/16 - 03:32 pm
Tags:
Novartis, Alcon, recalls
Novartis finds buyer to save 270 jobs at German plant
Fierce Pharma
Thu, 02/25/16 - 03:15 pm
Tags:
Novartis, Sandoz, layoffs, Germany, drug manufacturing
Novartis, Broad researchers find hope in potential gene target for intractable cancers
BioPharma Dive
Tue, 02/23/16 - 09:51 am
Tags:
Novartis, cancer, R&D
Novartis offices in South Korea raided over bribery concerns
Stat
Mon, 02/22/16 - 11:27 am
Tags:
Novartis, South Korea, bribery
Novartis' blood cancer drug bags a 'breakthrough' tag on the way to FDA filing
Fierce Biotech
Fri, 02/19/16 - 11:10 am
Tags:
Novartis, blood cancer, breakthrough status, PKC412, FDA
Novartis Hopes Transcend Buy Will Relieve The Pressure On Alcon
Seeking Alpha
Fri, 02/19/16 - 10:08 am
Tags:
Novartis, Alcon, Transcend Medical, M&A, glaucoma
Penn, Novartis to unveil $27M cell therapy center
Bizjournals.com
Tue, 02/16/16 - 07:52 pm
Tags:
Novartis, cell therapy, CAR-T
EU agency accepts Sandoz application for pegfilgrastim biosimilar
Yahoo/Reuters
Thu, 02/11/16 - 09:16 am
Tags:
Europe, Sandoz, Novartis, biosimilars, pegfilgrastim, Neulasta
Can Pharma Learn to Stop Worrying and Love Biosimilars?
Forbes
Thu, 02/11/16 - 08:28 am
Tags:
biosimilars, Novartis, Celltrion, Pfizer, Zarxio, CT-P13
Novartis defies naysayers with newfangled pay-for-performance deals on Entresto
Fierce Pharma
Wed, 02/10/16 - 10:00 pm
Tags:
Novartis, pay-for-performance, Cigna, Aetna, payers, Entresto
Big Pharma's new PCSK9, heart failure meds stuck in the slow lane. What gives?
Fierce Pharma Marketing
Wed, 02/10/16 - 03:20 pm
Tags:
PCSK9 inhibitors, heart failure, Praluent, Repatha, Novartis, Amgen, Sanofi, Regeneron
Pfizer keeps pushing on early hit Ibrance as Novartis, Lilly rivals near market
Fierce Pharma Marketing
Mon, 02/8/16 - 12:48 pm
Tags:
Pfizer, Ibrance, breast cancer, Novartis, Eli Lilly
3 Potential Blockbusters Moving the Needle for Big Pharma in 2016
Motley Fool
Mon, 02/8/16 - 10:23 am
Tags:
Big Pharma, JNJ, Novartis, Bristol-Myers Squibb, Darzalex, Entresto, Opdivo
Old Novartis cancer flagship Gleevec heads to pharmacies as lower-cost generic
BioPharma Dive
Wed, 02/3/16 - 08:59 pm
Tags:
Novartis, Gleevec, Sun Pharma, generics
Novartis braces for multibillion-dollar generics hit as Gleevec copies launch
Fierce Pharma
Mon, 02/1/16 - 11:13 pm
Tags:
Novartis, generics, Gleevec, Sun Pharma, blood cancer
What Does Novartis Expect from Pharmaceuticals?
Yahoo/Market Realist
Mon, 02/1/16 - 01:52 pm
Tags:
Novartis, earnings
Novartis blames slower-than-expected Entresto growth in US on insurer tardiness
BioPharma Dive
Fri, 01/29/16 - 08:22 pm
Tags:
Novartis, Entresto
Novartis reshuffles its $9B R&D operation to save $1B a year
Fierce Biotech
Wed, 01/27/16 - 04:16 pm
Tags:
Novartis, R&D, reorganization
Novartis taps Hospira-sale engineer exec Ball to revive slumping Alcon
Mass Device
Wed, 01/27/16 - 10:22 am
Tags:
Novartis, Hospira, Alcon, eye care
Novartis (NVS) Posts Lower-Than-Expected Earnings in Q4
NASDAQ.com
Wed, 01/27/16 - 10:19 am
Tags:
Novartis, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.